12:00 AM
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

CNV1014802 regulatory update

Convergence said FDA granted Orphan Drug designation for CNV1014802 to treat trigeminal neuralgia. The...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >